Within one scalable platform, Medidata enables remote patients to discover, evaluate, and enroll in your study virtually.

Real-time data is collected and securely stored for analytics and reporting. Engage larger populations of untapped patients with Direct-to-Patient (DtP).

Continuous remote monitoring of document review, targeted source data verification, and site activities enable risk remediation in real-time and with a fully auditable solution. Sites also gain efficiencies with the adoption of a single, standardized Imaging technology, delivering control and flexibility.

Supporting 360+ industry-sponsored COVID-19 studies in 70+ countries, Medidata teams up with Emerging and Mid-Sized Biopharma companies to pivot, adapt, and future proof their remote technologies to meet long-term compliance and future disruptions.

Accelerate study startup, access data, connect work, and scale and manage trials faster, all in one place.

Use a single sign-on (SSO) to centralize your workflows, data, and operations in one system for a continuous work experience across your teams. Leverage systematic and seamless processes to eliminate duplicate data entry, multiple data migrations, or unnecessary reconciliation efforts.

Operate with a single view of all cross-application data and activities to maintain full control, improve inspection readiness and operational efficiencies.

Optimize your trial design, operational feasibility, and trial performance according to data and predictive models benchmarking protocol, site and patient burden, and procedural cost. Leverage RWD to expand and better understand patient populations.

Accelerate enrollment through precise study, country, and site insights driven by cross-industry performance data and predictive models.

Improve study integrity, reduce risk, optimize efficiency and patient safety, unifying data capture and management in a single place for actionable insights and faster decision making.

Gain the ability to detect errors, trends, and anomalies to proactively perform root cause investigations and take corrective actions. Reduce trial risks with an RBQM approach to proactively enhance data quality.

Leverage cross-industry clinical trial data from 6 million patients and +23,000 trials to optimize your protocol feasibility, improve recruitment, and benchmark your study design to minimize patient burden and boost engagement and retention. Deliver powerful insights and the necessary evidence to increase the probability of success by connecting with real world data.

Use technology solutions designed from the patient perspective to meet patient preferences for data collection and participation, and seamlessly integrate into their everyday lives, improving the overall experience in clinical research operations.